Home Archives 2012 November

Monthly Archives: November 2012

Drug Patent Expirations for November 2012

TradenameApplicantGeneric NamePatent NumberPatent Expiration
SAMSCAOtsuka America Pharmtolvaptan5,258,510Nov 2, 2012
ALLEGRA ALLERGYSanofi Aventis Usfexofenadine hydrochloride6,399,632*PEDNov 11, 2012
ALLEGRASanofi Aventis Usfexofenadine hydrochloride6,187,791*PEDNov 11, 2012
ALLEGRA HIVESSanofi Aventis Usfexofenadine hydrochloride6,187,791*PEDNov 11, 2012
CHILDREN'S ALLEGRA ALLERGYSanofi Aventis Usfexofenadine hydrochloride6,399,632*PEDNov 11, 2012
ALLEGRA-D 12 HOUR ALLERGY AND CONGESTIONSanofi Aventis Usfexofenadine hydrochloride; pseudoephedrine hydrochloride6,187,791*PEDNov 11, 2012
CHILDREN'S ALLEGRA HIVESSanofi Aventis Usfexofenadine hydrochloride6,399,632*PEDNov 11, 2012
ALLEGRA-D 24 HOUR ALLERGY AND CONGESTIONSanofi Aventis Usfexofenadine hydrochloride; pseudoephedrine hydrochloride6,187,791*PEDNov 11, 2012
ALLEGRA ALLERGYSanofi Aventis Usfexofenadine hydrochloride6,187,791*PEDNov 11, 2012
ALLEGRA HIVESSanofi Aventis Usfexofenadine hydrochloride6,399,632*PEDNov 11, 2012
ALLEGRASanofi Aventis Usfexofenadine hydrochloride6,399,632*PEDNov 11, 2012
ALLEGRA-D 12 HOUR ALLERGY AND CONGESTIONSanofi Aventis Usfexofenadine hydrochloride; pseudoephedrine hydrochloride6,399,632*PEDNov 11, 2012
CHILDREN'S ALLEGRA ALLERGYSanofi Aventis Usfexofenadine hydrochloride6,187,791*PEDNov 11, 2012
ALLEGRA-D 24 HOUR ALLERGY AND CONGESTIONSanofi Aventis Usfexofenadine hydrochloride; pseudoephedrine hydrochloride6,399,632*PEDNov 11, 2012
CHILDREN'S ALLEGRA HIVESSanofi Aventis Usfexofenadine hydrochloride6,187,791*PEDNov 11, 2012
RAPAFLOWatson Labssilodosin5,780,485Nov 13, 2012
RAPAFLOWatson Labssilodosin5,403,847Nov 13, 2012
RAPAFLOWatson Labssilodosin6,015,819Nov 13, 2012
PEPCID COMPLETEMcneil Conscalcium carbonate; famotidine; magnesium hydroxide5,229,137*PEDNov 16, 2012
SURFAXINDiscovery Labslucinactant5,407,914Nov 17, 2012
LAMISILNovartisterbinafine5,856,355*PEDNov 18, 2012
LAMISIL ATNovartisterbinafine5,856,355*PEDNov 18, 2012
LAMISILNovartisterbinafine6,005,001*PEDNov 18, 2012
PROSCARMerckfinasteride5,886,184Nov 19, 2012
PROPECIAMerckfinasteride5,886,184Nov 19, 2012
CYCLOSETVerosciencebromocriptine mesylate5,756,513Nov 21, 2012
CYCLOSETVerosciencebromocriptine mesylate5,468,755Nov 21, 2012
CYCLOSETVerosciencebromocriptine mesylate5,866,584Nov 21, 2012
LATISSEAllerganbimatoprost8,017,655Nov 27, 2012
LUMIGANAllerganbimatoprost8,017,655Nov 27, 2012
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Subscribers have access to valuable datasets, including:

  • Clinical trial information
  • International patent families
  • International patent priority and PCT information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data export
  • More…
See the Database Preview and Plan Comparison.
Contact Us with any questions.